Search - tctmd.com

Displaying 321 - 340 of 1470

Sort: Relevancy | Date

Presentation TCT 2019

Epicardial LAAC to Reduce Atrial Fibrillation: AMAZE Rationale and Status

Presenter: DJ Lakkireddy

September 26, 2019

Presentation TCT 2019

TAVR Followed by LAA Closure: Implications for Bleeding, Stroke, and HALT

Presenter: Fabian Nietlispach

September 26, 2019

Presentation TCT 2019

LAA Closure in Patients With Prior Intracranial Hemorrhage

Presenter: Jens Erik Nielsen-Kudsk

September 26, 2019

Presentation TCT 2019

Clinical Rationale for LAA Closure After AF Ablation

Presenter: DJ Lakkireddy

September 26, 2019

Presentation TCT 2019

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Presenter: Brian Whisenant

September 26, 2019

Presentation TCT 2019

LAA Closure in the United States: Update From the NCDR LAAO Registry

Presenter: Matthew Price

September 26, 2019

Presentation TCT 2019

Making the Case for… - Surgical Perspectives: Not So Fast, We Need a Randomized Trial!

Presenter: Patrick McCarthy

September 26, 2019

Presentation TCT 2019

Making the Case for… - Anatomic Considerations and Optimizing Procedural Outcomes With Case Presentations

Presenter: Stanley Chetcuti

September 26, 2019

Presentation TCT 2019

Making the Case for… - Asian Perspectives: Balancing Age, Prevalence, Anatomy, and Culture

Presenter: Hasan Jilaihawi

September 26, 2019

Presentation TCT 2019

Making the Case for… - Case Presentation

Presenter: Brad Oldemeyer

September 26, 2019

Presentation TCT 2019

Making the Case for… - Case Presentation, Rationale, and UNLOAD Trial Updates

Presenter: Nicolas van Mieghem

September 26, 2019

Presentation TCT 2019

Making the Case for… - Rationale and Trial Updates

Presenter: Philippe Genereux

September 26, 2019

Presentation TCT 2019

Making the Case for… - Clinical Trial Updates, Anatomic Considerations, and Optimizing Procedural Outcomes

Presenter: Raj Makkar

September 26, 2019

Presentation TCT 2019

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies

Presenter: James Hermiller

September 26, 2019

Presentation TCT 2019

Case Presentation

Presenter: Steven Yakubov

September 26, 2019

Presentation TCT 2019

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

Presenter: Saibal Kar

September 26, 2019

Presentation TCT 2019

A Modern Approach to Bioprosthetic Valve Deterioration and Failure: Emerging Data After TAVR

Presenter: Davide Capodanno

September 26, 2019

Presentation TCT 2019

Remaining Data Gaps After the Low-Risk TAVR RCTs

Presenter: Michael Borger

September 26, 2019

Presentation TCT 2019

LAA Closure vs. NOACs: Pros and Cons, PRAGUE 17, and Additional Trials

Presenter: Vivek Reddy

September 26, 2019

Presentation TCT 2019

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Presenter: Michael Reardon

September 26, 2019

Advertisement

Epicardial LAAC to Reduce Atrial Fibrillation: AMAZE Rationale and Status

TAVR Followed by LAA Closure: Implications for Bleeding, Stroke, and HALT

LAA Closure in Patients With Prior Intracranial Hemorrhage

Clinical Rationale for LAA Closure After AF Ablation

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

LAA Closure in the United States: Update From the NCDR LAAO Registry

Making the Case for… - Surgical Perspectives: Not So Fast, We Need a Randomized Trial!

Making the Case for… - Anatomic Considerations and Optimizing Procedural Outcomes With Case Presentations

Making the Case for… - Asian Perspectives: Balancing Age, Prevalence, Anatomy, and Culture

Making the Case for… - Case Presentation

Making the Case for… - Case Presentation, Rationale, and UNLOAD Trial Updates

Making the Case for… - Rationale and Trial Updates

Making the Case for… - Clinical Trial Updates, Anatomic Considerations, and Optimizing Procedural Outcomes

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies

Case Presentation

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

A Modern Approach to Bioprosthetic Valve Deterioration and Failure: Emerging Data After TAVR

Remaining Data Gaps After the Low-Risk TAVR RCTs

LAA Closure vs. NOACs: Pros and Cons, PRAGUE 17, and Additional Trials

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content